Indiana House Bill HB1335

Indiana 2024 Regular Session

• Introduced: 1/10/24
• Refer: 1/10/24

Caption

Indiana vaccination adverse event reporting system.

Impact

The implementation of HB1335 is expected to amend several sections of the Indiana Code concerning public health. By creating a structured reporting framework for adverse events associated with childhood vaccines, the bill empowers health care providers to report incidents transparently while maintaining patient confidentiality. It also mandates the establishment of a searchable database that will allow for public access to aggregated, anonymized data about reported adverse events, which is geared towards fostering public trust in vaccines by being transparent about their safety and associated risks.

Summary

House Bill 1335 aims to establish the Indiana Vaccination Adverse Event Reporting System (IVAERS), which is designed to collect and report information about adverse events related to childhood vaccinations. Under the bill, health care providers will be required to report these occurrences to the Indiana Department of Health, enabling a systematic collection of data regarding vaccine-related incidents. The initiative is intended to enhance transparency and ensure that any negative reactions to vaccines are documented and analyzed, thereby improving the overall monitoring of vaccine safety in the state.

Contention

One of the notable points of contention surrounding HB1335 lies in the balance it seeks to strike between public health transparency and individual privacy rights. The bill imposes strict confidentiality requirements on the personal health information reported through IVAERS, making unauthorized disclosures a Class A misdemeanor. Critics may argue that this measure, while important for protecting sensitive information, could potentially limit comprehensive analysis of vaccine-related issues by restricting some access to data. Furthermore, discussions around the potential ramifications of linking vaccination with adverse events, such as autism spectrum disorders, could spur additional public debate regarding vaccine safety and regulation.